ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Reorganization Proposals Create opposition Among Some Advisors

June 17, 1988

Rauscher Tabs Oak Ridge Immunologists To Head Basic Research At Frederick

August 30, 1974

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

Long-Term Remissions Shown With Chemo Plus Radiation

September 29, 2006

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013